NEW YORK, June 30 - The Translational Genomics Research Institute has entered a collaboration with the Mayo Clinic Cancer Center, Arizona State University, and the University of Arizona to study melanoma, officials from the research organizations said today.
More than 30 investigators and clinicians from the four centers met today at the Mayo Clinic in Scottsdale, Ariz., to begin "drafting a strategic plan to structure the collaboration," according to a statement.
"Our discussions today with colleagues from TGen and the universities will augment the ongoing work of our multidisciplinary melanoma team," said Laurence Miller, director of the Mayo Clinic Cancer Center, Scottsdale.
Investigators at TGen, Mayo Clinic Cancer Center, and Arizona State University have already submitted a grant proposal to the National Institutes of Health to use molecular genetics to predict clinical responses to immunotherapy for melanoma.
The four research groups plan to work collaboratively on additional topics in the future, officials said.